Ann-Kathrin Kull

Mrs. Ann-Kathrin Kull


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2023 in Foods
Verified
Journal Article
Open access
PDF file
SSSydney Schorb
Sydney Schorb
KGKatharina Gleiss
Katharina Gleiss
RWRoland Wedekind
Roland Wedekind
ESEero Suonio
Eero Suonio
AKAnn-Kathrin Kull
Ann-Kathrin Kull
Dirk W. LachenmeierDirk W. Lachenmeier
Dirk W. Lachenmeier
This study examines the occurrence of the artificial sweetener aspartame (E951) in foods and beverages sampled by food control authorities in Germany between 2000 and 2022. The dataset was obtained through the Consumer Information Act. Out of 53,116 samples analyzed, aspartame was present in 7331 samples (14%), of which 5703 samples (11%) in nine major food groups were further evaluated. The results showed that aspartame was most commonly found in powdered drink bases (84%), flavored milk drinks (78%), chewing gum (77%), and diet soft drinks (72%). In the solid food groups, the highest mean aspartame content was detected in chewing gum (1543 mg/kg, n = 241), followed by sports foods (1453 mg/kg, n = 125), fiber supplements (1248 mg/kg, n = 11), powdered drink bases (1068 mg/kg, n = 162), and candies (437 mg/kg, n = 339). Liquid products generally had the highest aspartame content in diet soft drinks (91 mg/L, n = 2021), followed by regular soft drinks (59 mg/L, n = 574), flavored milk drinks (48 mg/kg, n = 207), and mixed beer drinks (24 mg/L, n = 40). These results suggest that aspartame is commonly used in some foods and beverages in Germany. The levels of aspartame found were generally within the legal limits set by the European Union. These findings provide the first comprehensive overview of aspartame in the German food market and may be particularly useful in informing the forthcoming working groups of the WHO International Agency for Research on Cancer (IARC) and the WHO/FAO Joint Expert Committee on Food Additives (JECFA), which are in the process of evaluating the human health hazards and risks associated with the consumption of aspartame.

13 May 2024 in Proceedings
Verified
Conference Paper
Open access
PDF file
AKAnn-Kathrin Kull
Ann-Kathrin Kull
Dirk W. LachenmeierDirk W. Lachenmeier
Dirk W. Lachenmeier
In the European Union (EU), the labeling of coffee and coffee by-products adheres to comprehensive regulations aimed at ensuring product transparency and consumer safety. According to Regulation (EU) 1169/2011, the mandatory particulars that must appear on coffee labels include the name of the food, the net quantity, the date of minimum durability, and the name and address of the food business operator. For coffee by-products classified as novel foods—those not recognized within the EU prior to 1997—additional stipulations under Regulation (EU) 2015/2283 require a rigorous approval process. This process involves a safety assessment and the possibility of a simplified notification procedure if the product has a history of safe use outside the EU. The already approved novel coffee by-product ingredients such as coffee leaves and cascara (dried coffee cherry pulp) must also adhere to specific labeling requirements, which dictate precise naming conventions and usage categories that align with safety standards and consumer information needs. These detailed labeling requirements are pivotal for maintaining the integrity of coffee products sold within the EU, ensuring that all items, from traditional coffee to innovative coffee by-product-based ingredients, meet the highest standards of safety and consumer information. This article describes from a practical perspective the labeling standards for coffee and coffee by-products, and points out challenges in the implementation of the regulations.

8 August 2024 in Proceedings
Verified
Conference Paper
Open access
PDF file
KHKatharina Höfflin
Katharina Höfflin
VKVeronika Kurz
Veronika Kurz
YKYvonne Köder
Yvonne Köder
KSKristina Schmied
Kristina Schmied
VBVerena Bock
Verena Bock
Dirk W. LachenmeierDirk W. Lachenmeier
Dirk W. Lachenmeier
Caffeine is an alkaloid belonging to the methylated xanthine family. It is found in various foods of plant origin, including tea leaves, guarana berries, and coffee beans. Due to its stimulating effect on the central nervous system and the associated increase in alertness and reduction in tiredness, caffeine is specifically added to some foods, such as food supplements. Claims about the positive physiological effects of caffeine are health claims within the definition of the European Union (EU) Health Claims Regulation and must be authorised before use. Despite a positive opinion from the European Food Safety Authority, regulation of the authorisation of caffeine claims was rejected due to a veto by the European Parliament. As a result, health claims are currently not regulated for caffeine in all EU member states, and the transitional on-hold status also no longer applies for most claims. Therefore, products with health claims regarding caffeine are still observed within the context of governmental food-control activities. To investigate how these are currently used on the market, internet research (n = 188) was carried out. The sample included foods that naturally contain caffeine or to which it is frequently added, namely coffee, tea, non-alcoholic soft drinks and mixed drinks, as well as food supplements, including sports nutrition products. Furthermore, the labelling of official samples that were conspicuous in relation to caffeine in the years 2019–2023 (n = 136) was included in the evaluation. The products most frequently advertised with unregulated health claims for caffeine were food supplements (31% of 135 products). On the other hand, health claims were least frequently used for coffee (4% of 77 products) and tea (18% of 33 products). For all product groups, health claims were mainly made regarding improved concentration and performance/energy. The individual effects the health claims referred to differed between the product groups. In the case of coffee and tea, the advertised effects are mainly limited to increased energy and performance in the form of a “kick” or “boost”. A wider range of different health claims are used for food supplements and alcohol-free beverages, including claims relating to stamina and alertness. In general, the tendency was observed for health claims to be advertised more frequently on the internet than on the product labelling itself. This study exposes a critical issue: while scientific evidence supports some health claims for caffeine, they still remain unregulated, complicating enforcement and creating public confusion. Prompt regulatory revision is needed to align these claims with scientific validations, ensuring both accuracy and regulatory compliance.

4 September 2023 in Proceedings
Verified
Conference Paper
Open access
PDF file
AKAnn-Kathrin Kull
Ann-Kathrin Kull
TRTabata Rajcic de Rezende
Tabata Rajcic de Rezende
Dirk W. LachenmeierDirk W. Lachenmeier
Dirk W. Lachenmeier
In addition to the well-known coffee bean, many other parts of the coffee plant can be used as food. These materials have been traditionally used in some coffee-producing countries but were not known in the European Union (EU) before 1997, and are therefore classified as novel in the EU and require approval before being placed on the market. Authorization of novel foods is carried out in accordance with the requirements of Article 10 of Regulation (EU) 2015/2283. For certain categories, such as plant products, there is also the possibility of a simplified notification as a “traditional food from a third country” according to Articles 14 and 15 of Regulation (EU) 2015/2283 if the product has a "history of safe food use" in a country outside the EU. Currently, only infusions of coffee leaves and cherry pulp and the dried cherry pulp as such (also known as cascara (“husk”)) are permitted in the EU as traditional foods from third countries for certain categories. When using authorized novel foods, the general legal requirements for food as well as the specific requirements of Regulation (EU) 2017/2470 (the so-called Union list) must be observed. The mandatory labeling elements according to the Food Information Regulation (Regulation (EU) 1169/2011) include the name of the food, the list of ingredients, the net quantity, the name and address of the food business operator, the date of minimum durability, the instructions for use, and the nutrition declaration. In addition, the Union list specifies certain labeling elements, such as the legally defined name of the authorized novel food such as “coffee cherry pulp”, “cascara (coffee cherry pulp)”, or “infusion from coffee leaves” and the categories of use, which must also be complied with.

17 April 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
SSSydney Schorb
Sydney Schorb
KGKatharina Gleiss
Katharina Gleiss
RWRoland Wedekind
Roland Wedekind
ESEero Suonio
Eero Suonio
AKAnn-Kathrin Kull
Ann-Kathrin Kull
Dirk W. LachenmeierDirk W. Lachenmeier
Dirk W. Lachenmeier
This study aimed to investigate the occurrence of the artificial sweetener aspartame (E951) in a wide range of foods and beverages sampled by food control authorities in Germany between 2000 and 2022. The dataset was obtained through the Consumer Information Act. The results showed that aspartame was present in a wide range of product groups tested, most commonly in powdered drink bases (84%) and flavored milk drinks (78%). In the solid food groups, the highest mean aspartame content was found in chewing gum (1543 mg/kg, n=241), followed by sports foods (1453 mg/kg, n=125), fiber supplements (1248 mg/kg, n=11), powdered drink bases (1068 mg/kg, n=162), and candies (437 mg/kg, n=339). Liquid products generally had the highest aspartame content in diet soft drinks (91 mg/l, n=2021), followed by regular soft drinks (59 mg/l, n= 574), flavored milk drinks (48 mg/kg, n=207), and mixed beer drinks (24 mg/l, n=40). These results suggest that aspartame is widely used in foods and beverages in Germany and that certain product groups contain higher concentrations of the sweetener than others. However, the levels of aspartame found were generally within the legal limits set by the European Union. These findings provide the first comprehensive overview of aspartame in the German food market and may be particularly useful in informing the forthcoming working groups of the WHO International Agency for Research on Cancer (IARC) and the WHO/FAO Joint Expert Committee on Food Additives (JECFA), which are in the process of evaluating the human health hazards and risks associated with the consumption of aspartame.

16 September 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Dirk W. LachenmeierDirk W. Lachenmeier
Dirk W. Lachenmeier
CBClaudia Baumung
Claudia Baumung
EDElena Dilger
Elena Dilger
AKAnn-Kathrin Kull
Ann-Kathrin Kull
MGMelisa Nazire Güneri
Melisa Nazire Güneri
SWStephan Walch
Stephan Walch
Methylene blue is the active substance of an authorised medicinal product and is increasingly taken as a self-administered oral preparation. It is offered to final consumers in dosed form, mostly declared as a laboratory chemical, reagent or dye rather than as a food supplement. No health-based guidance value (HBGV) for oral intake has been established in any jurisdiction. Points of departure were derived from 2-year gavage bioassays: a no-observed-adverse-effect level (NOAEL) of 1.8 mg/kg body weight per day for oxidative erythrocyte injury, and benchmark dose lower confidence limits (BMDL) of 2.6 and 10.3 mg/kg body weight per day for pancreatic islet and small intestinal neoplasms. A survey of 63 products offered to final consumers in eight European Union (EU) member states found that only five stated an intake amount. Intakes estimated from these statements, co-marketed consumer literature, user reports and documented oral therapeutic regimens spanned 6 to 200 mg per day. Margins of exposure fell from 20.9 to 0.6 against the NOAEL and from 30.2 to 0.9 against the BMDL, so that neither the required margin of 100 nor that of 10,000 was attained in any scenario, including the lowest, which is a supplier's own recommendation. No presentation examined could deliver an amount within a provisional HBGV of 0.018 mg/kg body weight per day, or 1.26 mg per day for an adult (based on NOAEL with uncertainty factor of 100 and adult bodyweight of 70 kg).